הזדמנות שהוחמצה עבור ישראל וסעודיה

הערכה

The piece argues that the real prize in Israel Saudi normalization is not security or trade but biomedical collaboration. Both countries have complementary assets: Israeli innovation and Saudi capital and market access. The Palestinian issue is treated as a political constraint that can be managed, not a dealbreaker. Watch whether any concrete joint research initiatives or investment funds emerge before a formal normalization agreement.